Literature DB >> 20360281

Simplifying adherence in schizophrenia.

Suzanne M Hardeman1, Richard K Harding, Meera Narasimhan.   

Abstract

Treatment nonadherence is a formidable challenge in today's clinical practice. Despite decades of focused research, medication adherence continues to be a significant risk factor for poor prognosis in schizophrenia. Studies demonstrate that no single strategy is effective for all patients and that a multidisciplinary approach customized to the patient's individual needs results in improved adherence rates. This Open Forum presents a comprehensive model for organizing and incorporating current and future evidence-based strategies with a focus on educational strategies, psychotherapeutic techniques, and a strong therapeutic alliance.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20360281     DOI： 10.1176/ps.2010.61.4.405

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN： 1075-2730            Impact factor:   3.084


  8 in total

1.  Effect of a motivational intervention on exercise behavior in persons with schizophrenia spectrum disorders.

Authors:  Lora Humphrey Beebe; Kathy Smith; Renee Burk; Kelly McIntyre; Olivera Dessieux; Abbas Tavakoli; Clif Tennison; Dawn Velligan
Journal:  Community Ment Health J       Date:  2010-11-27

2.  What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders.

Authors:  Subho Chakrabarti
Journal:  World J Psychiatry       Date:  2014-06-22

3.  Nurses' perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey.

Authors:  Robin Emsley; Koksal Alptekin; Jean-Michel Azorin; Fernando Cañas; Vincent Dubois; Philip Gorwood; Peter M Haddad; Dieter Naber; José Manuel Olivares; Georgios Papageorgiou; Miguel Roca; Pierre Thomas; Ludger Hargarter; Andreas Schreiner
Journal:  Ther Adv Psychopharmacol       Date:  2015-12

4.  Psychotic relapse and associated factors among patients attending health services in Southwest Ethiopia: a cross-sectional study.

Authors:  Mahlet Fikreyesus; Matiwos Soboka; Garumma Tolu Feyissa
Journal:  BMC Psychiatry       Date:  2016-10-20       Impact factor: 3.630

5.  Association between adherence to and persistence with atypical antipsychotics and psychiatric relapse among US Medicaid-enrolled patients with schizophrenia.

Authors:  Jessica Panish; Sudeep Karve; Sean D Candrilli; Riad Dirani
Journal:  J Pharm Health Serv Res       Date:  2013-01-07

6.  Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers.

Authors:  Solomon Teferra; Charlotte Hanlon; Teferra Beyero; Lars Jacobsson; Teshome Shibre
Journal:  BMC Psychiatry       Date:  2013-06-17       Impact factor: 3.630

7.  Use of quetiapine XR and quetiapine IR in clinical practice for hospitalized patients with schizophrenia: a retrospective study.

Authors:  Lars Eriksson; Teresa Hallerbäck; Leif Jørgensen; Andreas Carlborg
Journal:  Ther Adv Psychopharmacol       Date:  2012-12

8.  A Flexible-Dose Study of Paliperidone ER in Patients With Nonacute Schizophrenia Previously Treated Unsuccessfully With Oral Olanzapine.

Authors:  Moshe Kotler; Nesrin Dilbaz; Fernanda Rosa; Periklis Paterakis; Vihra Milanova; Anatoly B Smulevich; Marjolein Lahaye; Andreas Schreiner
Journal:  J Psychiatr Pract       Date:  2016-01       Impact factor: 1.325
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.